A Randomized Study Comparing Levofloxacin, Omeprazole, Nitazoxanide, and Doxycycline versus Triple Therapy for the Eradication of Helicobacter pylori-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Randomized Study Comparing Levofloxacin, Omeprazole, Nitazoxanide, and Doxycycline versus Triple Therapy for the Eradication of Helicobacter pylori

Published:2011-11 Issue:11 Volume:106 Page:1970-1975
ISSN:0002-9270
Container-title:American Journal of Gastroenterology
language:en
Short-container-title:

Author:

Basu Patrick P,Rayapudi Krishna,Pacana Tommy,Shah Niraj James,Krishnaswamy Nithya,Flynn Molly

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Link

http://www.nature.com/articles/ajg2011306.pdf

Reference37 articles.

1. Helicobacter pylori infection and nonmalignant diseases.;de Vries;Helicobacter,2010

2. Antimicrobial resistance incidence and risk factors among H. pylori-infected persons, United States.;Duck;Emerg Infect Dis,2004

3. Helicobacter pylori and gastric cancer: a new paradigm for inflammation-associated epithelial cancers.;Houghton;Gastroenterology,2005

4. American College of Gastroenterology guideline on the management of Helicobacter pylori infection.;Chey;Am J Gastroenterol,2007

5. Helicobacter pylori rescue therapy after failure of two eradication treatments.;Gisbert;Helicobacter,2005

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Updates to the Diagnosis and Clinical Management of Helicobacter pylori Infections;Clinical Chemistry;2023-07-19

2. Therapeutic efficacy of proton pump inhibitor (omeprazole) on cryptosporidiosis parvum in immunosuppressed experimental mice;Journal of Parasitic Diseases;2023-05-18

3. Treatment of Helicobacter pylori Infection in Patients with Penicillin Allergy;Antibiotics;2023-04-10

4. Molecular Mechanisms of Antibiotic Resistance and Novel Treatment Strategies for Helicobacter pylori Infections;Tropical Medicine and Infectious Disease;2023-03-11

5. Repurposing Benztropine, Natamycin, and Nitazoxanide Using Drug Combination and Characterization of Gastric Cancer Cell Lines;Biomedicines;2023-03-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3